InvestorsHub Logo
Followers 1
Posts 836
Boards Moderated 0
Alias Born 03/30/2007

Re: None

Saturday, 10/20/2007 2:30:10 PM

Saturday, October 20, 2007 2:30:10 PM

Post# of 45401
Dr. Stoll noted that the potential for a new therapeutic approach to the treatment of ADHD is clear and, if clinically safe and effective, CX717 could meet many of the current market needs.

http://www.cortexpharm.com/html/news/07/02-23-07.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News